ArticleCancer gene therapy2006

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

S Varghese et al.PubMed ↗Publisher ↗

No numbers read from the abstract.